CITIIQ
27.8.2020 12:32:13 CEST | Business Wire | Press release
CitiIQ (http://www.citiiq.com ) has applied its novel measurement standard to 1,170 global cities as an important step toward measuring the 4,000 cities of the world with a population over 100,000.
The 1,170 cities include those with populations greater than 500,000, the world’s country capitals, and the state capitals of Brazil, India China and the USA.
“Increasingly, the health and wellbeing of people depend upon the effectiveness of their city,” says Don Simmonds, Chief Executive Officer of CitiIQ. “Municipal leaders face immense challenges and benefit greatly when comprehensive, comparable data is available to guide their decisions.”
Most cities struggle to translate disparate data into actions that can make life better for their citizens. The CitiIQ measurement system is an objective assessment of the overall health and wellbeing of a city. It converts raw data into scores out of 100 so that city elements are readily compared within a given city, or with other cities around the world.
CitiIQ uses an evidence-based methodology to score 35 essential elements, or Considerations, within five prioritized Dimensions including Basic Needs, Competitiveness, Opportunity, Livability, and Destiny. Using an intuitive online dashboard, a city’s measurements are readily available to clients through a cloud-based annual subscription.
“The CitiIQ measurement helps immensely in understanding the factors that influence a city,” says Harry Loubser, Managing Director of Unashamedly Ethical based in Cape Town, South Africa. “It's value to municipal leaders is readily apparent but the ability to compare city to city across so much of the world is a powerful advantage. We can clearly identify where best practise has been applied, but also illuminate cities with the greatest needs.”
The CitiIQ system is easy to use, economical, and effective with no need to purchase new software or abandon existing metrics. Aligned with the United Nations Sustainable Development Goals, CitiIQ provides a practical way for a city to mark progress toward SDG achievement.
City Administrators appreciate the integration of economic, environmental, social and cultural infrastructure measures reflecting how a city actually functions. The algorithm normalizes data into a comparable, holistic picture of their city’s strengths and weaknesses bringing coherence and comparability to their operations and an ability to compare with other cities.
In April 2020 CitiIQ was selected by UN-Habitat to develop a COVID-19 Readiness and Responsiveness tracking site for more than 1,000 global cities. Data was often unavailable at a city level where the real battle is fought. The scoring reflects both how ready a city was for COVID-19 and how well they are responding to the pandemic. COVID-19 data is collected daily for the 1,000 cities supporting improve responses to the pandemic. Visit: https://unhabitat.citiiq.com/ .
About CitiIQ
CitiIQ is a comprehensive system that objectively measures the overall health and wellbeing of a city. Using an intuitive online dashboard style interface, a city’s measurements are made readily available to clients through a cloud-based annual subscription.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200827005026/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference5.6.2026 18:00:00 CEST | Press release
- ALYFTREK Phase 3 data on children with cystic fibrosis ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including F/F and F/MF shows 65% reached sweat chloride levels of <30 mmol/L; Vertex on track to initiate global regulatory submissions in first half of 2026 - - Long-term 96-week interim analyses from two open-label extension studies demonstrate positive safety and efficacy profile of ALYFTREK in people with cystic fibrosis ages 6 and older -- Phase 3 data on TRIKAFTA® in children 1 to <2 years also presented; Vertex has initiated global regulatory submissions - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the potentially transformative impact of treating cystic fibrosis (CF) with ALYFTREK ® (vanzacaftor/tezacaftor/deutivacaftor) in children ages 2 to 5, as well as data from 96-week interim analyses of two open-label extension studies of ALYFTREK in children 6 to 11 years and people 12 years and older demonstrating
Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi5.6.2026 13:00:00 CEST | Press release
Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260605704506/en/ K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making. Owkin and Sanofi have collaborated since 2021 through a €90 million strategic partnership focused on target identification in oncology and patient subgrouping. The collaboration was later expanded to include drug positioning for Sanofi’s immunology pipeline. This new collaboration represents the next evolution in the partnership. During the five-year collaboration, Owkin will lead the end-to-end development of novel AI-driven biopharma agents purpose-built
DFNS Rebrands as the Core Banking Platform for Digital Assets5.6.2026 12:41:00 CEST | Press release
DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital assets. The company is introducing a new logo, website, and market position as fintechs and institutions move their products and operations onchain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603859127/en/ Banks, fintechs, asset managers, trading firms, payment providers, market infrastructures, and clearing houses have stopped asking how to "add crypto." They're asking how to run financial products, controls, workflows, and client services on blockchain rails, with the reliability expected of core infrastructure. Some are going further still, exploring whether the blockchain can serve as the ledger itself, where an account is an onchain object rather than a row in a database. Where IBANs, virtual accounts, and blockchain wallets converge into one governed financial account. “DFNS was built
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.6.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seventeen newly hired non-executive employees. The equity awards were granted on June 1, 2026 and consisted of options to purchase an aggregate of 157,000 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 74,700 shares. The options have an exercise price per share equal to $14.19, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restrict
Renewable Electricity, Soft Wheat Flour From Regenerative Agriculture, Initiatives to Support Local Communities: Barilla Shares These and Other Projects in “Stories of Sustainability.”5.6.2026 10:00:00 CEST | Press release
Barilla continues to advance its commitment to tastier products with less sugar and salt;An investment of 30 million euros in 2025 to quadruple photovoltaic capacity across plants, as part of a €168 million five-year plan focused on energy efficiency, renewable energy and sustainable water management.Barilla continues to expand regenerative agriculture practices across its global value chain, with over 816,000 tons of raw materials sourced through the Barilla Sustainable Farming program.4,000 tons of products donated worldwide and €2 million allocated to social causes in 2025, supporting communities across Barilla’s global footprint through food donations and social initiatives. A slimmer Tagliatelle pack that saves 150 tons of cardboard and cuts transport-related CO₂ emissions by 20%1; ready-made sauce jars made with around 65% recycled glass; the progressive scaling of regenerative agriculture practices across Barilla’s value chain and initiatives supporting inclusion and equal oppor
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom